GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Expenditure | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr | ₹2,327 Cr | ₹2,567 Cr |
What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2025 | ₹2,545 Cr |
Mar2024 | ₹2,447 Cr |
Mar2023 | ₹2,516 Cr |
Mar2022 | ₹2,327 Cr |
Mar2021 | ₹2,567 Cr |
How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2025 | ₹2,545 Cr | 3.99 | |
Mar2024 | ₹2,447 Cr | -2.73 | |
Mar2023 | ₹2,516 Cr | 8.11 | |
Mar2022 | ₹2,327 Cr | -9.34 | |
Mar2021 | ₹2,567 Cr | - |
Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹54,924.6 Cr | -1.2% | -2.3% | 27.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -1.2% |
-2.3% |
27.2% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses